Clinical Trials
Recent Trials
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
Natural History Study of Patients With Neurofibromatosis Type I
Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
Research Evidence
Peer-reviewed studies linked via MeSH term "Neurofibroma" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 404029005
- UMLS CUI
- C0027830
- Fully Specified Name
- Neurofibroma (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 26
- Clinical Trials
- 4
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.